Folic Acid Salt Study (FISFA Zambia)
This study, called FISFA Zambia, is looking at how well iodized salt fortified with folic acid (FISFA) can increase folate levels in women in Zambia. Folate deficiency can lead to neural tube defects (serious birth defects of the brain and spine). Researchers want to see if adding folic acid to salt, which people use daily, can help prevent these defects. You might be able to join if you are a woman between 18 and 45 years old, not pregnant or breastfeeding, and do not plan to get pregnant. The study will measure changes in your blood folate levels over six months to see if the fortified salt is effective. The current status of this study is unclear.
- Study design
- This is an interventional study planning to enroll 250 women. It is a nonrandomized controlled intervention trial.
- What's involved
- You would consume salt with folic acid for six months instead of your usual salt. You would also have blood drawn four times and fill out surveys.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your folate levels will be measured at baseline, month 1, month 3, and month 6 (the endpoint).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Folic Acid Salt Study (FISFA Zambia)
At a glance
Conditions
Where it's being run
2 sites across 2 statesStudy leadership
- Anastasia A Smith, DrPH · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Measure change in median and mean serum folate levels between baseline, month 1, month 3 and month 6 (endpoint)0-6 months
Evaluate folate blood levels pre and post intervention
- Measure change in median and mean red blood cell folate levels between baseline, month 1, month 3 and month 6 (endpoint)0-6 months
Evaluate folate blood levels pre and post intervention